Skip to main content

Table 5 Progression-free survival

From: The prognostic value of nestin expression in newly diagnosed glioblastoma: Report from the Radiation Therapy Oncology Group

 

Low

Intermediate

High

Months

% Alive

No. at Risk

% Alive

No. at Risk

% Alive

No. at Risk

0

100%

17

100%

70

100%

66

12

29%

5

27%

19

23%

15

24

12%

2

11%

8

6%

4

36

12%

2

4%

2

0

0

48

12%

1

0

0

0

0

60

12%

1

0

0

0

0

Median Dead/Total

9.9 mo. 16/17

7.2 mo. 69/70

5.8 mo. 66/66

  1. Pairwise Comparisons using Log-rank test: Low vs. Intermediate (0.2), Low vs. High (0.08), Intermediate vs. High (0.31).
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us